Ftse Mib
33.573,41
-0,40%
DAX
18.155,24
-0,04%
S&P 500
5.470,73
0,03%
NASDAQ
17.779,39
0,35%
Bitcoin
61.384,54
-0,69%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO) Notizie

TBIO

Telesis Bio (TBIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TBIO
DataOraFonteTitoloSimboloCompagnia
12/06/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/06/202402:40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
10/05/202412:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
09/05/202422:05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/05/202422:05GlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
18/04/202415:00GlobeNewswire Inc.Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipNASDAQ:TBIOTelesis Bio Inc
28/03/202421:05GlobeNewswire Inc.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
06/03/202400:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
26/02/202415:15GlobeNewswire Inc.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
13/11/202322:22GlobeNewswire Inc.Telesis Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
07/11/202315:00GlobeNewswire Inc.Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023NASDAQ:TBIOTelesis Bio Inc
03/11/202317:00GlobeNewswire Inc.Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNANASDAQ:TBIOTelesis Bio Inc
28/09/202321:48GlobeNewswire Inc.Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGSNASDAQ:TBIOTelesis Bio Inc
29/08/202322:05GlobeNewswire Inc.Telesis Bio Appoints William J. Kullback Chief Financial OfficerNASDAQ:TBIOTelesis Bio Inc
10/08/202322:05GlobeNewswire Inc.Telesis Bio Reports Second Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
04/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TBIOTelesis Bio Inc
03/08/202323:00GlobeNewswire Inc.Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023NASDAQ:TBIOTelesis Bio Inc
27/07/202323:28Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TBIOTelesis Bio Inc
08/06/202315:05GlobeNewswire Inc.Telesis Bio to Present at Jefferies Healthcare Conference 2023NASDAQ:TBIOTelesis Bio Inc
06/06/202309:00GlobeNewswire Inc.Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023NASDAQ:TBIOTelesis Bio Inc
05/06/202323:30GlobeNewswire Inc.Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common StockNASDAQ:TBIOTelesis Bio Inc
31/05/202323:29GlobeNewswire Inc.Telesis Bio Secures Financing of $28.0 MillionNASDAQ:TBIOTelesis Bio Inc
23/05/202315:00GlobeNewswire Inc.Telesis Bio to Present at SynBioBeta 2023NASDAQ:TBIOTelesis Bio Inc
22/05/202318:00GlobeNewswire Inc.Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning KitNASDAQ:TBIOTelesis Bio Inc
18/05/202316:00GlobeNewswire Inc.Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep KitNASDAQ:TBIOTelesis Bio Inc
15/05/202315:00GlobeNewswire Inc.Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)NASDAQ:TBIOTelesis Bio Inc
11/05/202322:05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
27/04/202322:05GlobeNewswire Inc.Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023NASDAQ:TBIOTelesis Bio Inc
31/03/202315:00GlobeNewswire Inc.Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-upNASDAQ:TBIOTelesis Bio Inc
22/03/202311:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TBIOTelesis Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TBIO

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
SRG
Snam
BIT
LDO
Leonardo
BIT
G
Generali
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network